6
Participants
Start Date
October 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
October 31, 2009
Gemcitabine
Gemcitabine 1000mg/m\^2 on day 1 every 14 days Cycles of treatment will be repeated every 2 weeks until disease progression, intolerable toxicity, or the development of any of the criteria for study removal
Oxaliplatin
Oxaliplatin 100mg/m\^2 on day 2 every 14 days Cycles of treatment will be repeated every 2 weeks until disease progression, intolerable toxicity, or the development of any of the criteria for study removal
Emory University Winship Cancer Institute, Atlanta
Collaborators (1)
Sanofi
INDUSTRY
Emory University
OTHER